These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 28393050)
1. How Do the Virulence Factors of Mattock E; Blocker AJ Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050 [No Abstract] [Full Text] [Related]
5. Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Ashida H; Ogawa M; Mimuro H; Sasakawa C Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985 [TBL] [Abstract][Full Text] [Related]
6. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481 [TBL] [Abstract][Full Text] [Related]
10. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Phalipon A; Sansonetti PJ Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832 [TBL] [Abstract][Full Text] [Related]
11. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276 [TBL] [Abstract][Full Text] [Related]
12. A new paradigm of bacteria-gut interplay brought through the study of Shigella. Sasakawa C Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(3):229-43. PubMed ID: 20228623 [TBL] [Abstract][Full Text] [Related]
14. Implications of Spatiotemporal Regulation of Shigella flexneri Type Three Secretion Activity on Effector Functions: Think Globally, Act Locally. Campbell-Valois FX; Pontier SM Front Cell Infect Microbiol; 2016; 6():28. PubMed ID: 27014638 [TBL] [Abstract][Full Text] [Related]
15. The versatility of Shigella effectors. Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C Nat Rev Microbiol; 2008 Jan; 6(1):11-6. PubMed ID: 18059288 [TBL] [Abstract][Full Text] [Related]
16. Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century. Anderson M; Sansonetti PJ; Marteyn BS Front Cell Infect Microbiol; 2016; 6():45. PubMed ID: 27148494 [TBL] [Abstract][Full Text] [Related]
19. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968 [TBL] [Abstract][Full Text] [Related]
20. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Batani G; Vezzani G; Lashchuk S; Allaoui A; Cardamone D; Raso MM; Boero E; Roscioli E; Ridelfi M; Gasperini G; Pizza M; Rossi O; Berlanda Scorza F; Micoli F; Rappuoli R; Sala C Front Immunol; 2024; 15():1374293. PubMed ID: 38680489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]